Symbols / PRVB
PRVB Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
- Provention Bio Stock Soars on $2.9 Billion Acquisition by Sanofi - Barron's Mon, 13 Mar 2023 07
- Provention (PRVB) Skyrockets 260% on Buyout Offer From Sanofi - Yahoo Finance ue, 14 Mar 2023 07
- Is the Options Market Predicting a Spike in Provention Bio (PRVB) Stock? - Nasdaq ue, 12 Jan 2021 08
- 1 Green Flag and 1 Red Flag for Provention Bio - The Motley Fool hu, 22 Sep 2022 07
- Provention Bio: Tzield Finally Approved, But Neutral On Its Commercial Launch - Seeking Alpha Mon, 02 Jan 2023 08
- Provention Bio News: Why PRVB Stock Is Skyrocketing Today - Nasdaq Mon, 10 Jun 2019 07
- Provention (PRVB) Up on Deal With Sanofi for Diabetes Drug - Yahoo Finance Fri, 07 Oct 2022 07
- Provention Bio: Ability To Expand T1D Market Presence With Second Half 2023 Data - Seeking Alpha ue, 07 Feb 2023 08
- Provention Bio: Good Prospects In T1D, But Patent Protection A Worry (PRVB) - Seeking Alpha Wed, 22 Feb 2023 08
- Provention Bio: Sanofi Acquires Provention Bio With A 273% Premium (NASDAQ:PRVB) - Seeking Alpha Sun, 26 Mar 2023 07
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for PRVB
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|